(Q38172847)

30 August 2017

title

The potential of biomarkers in psychiatry: focus on proteomics (English)

1 reference

30 August 2017

0 references

0 references

Izabela Sokolowska

1

1 reference

30 August 2017

Armand G Ngounou Wetie

2

1 reference

30 August 2017

Kelly Wormwood

3

1 reference

30 August 2017

Johannes Thome

4

1 reference

30 August 2017

Costel C Darie

5

1 reference

30 August 2017

Alisa G Woods

6

1 reference

30 August 2017

publication date

20 December 2013

1 reference

Journal of Neural Transmission

30 August 2017

published in

1 reference

30 August 2017

volume

122 Suppl 1

1 reference

30 August 2017

page(s)

S9-18

1 reference

The genetics of bipolar disorder

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

Proteomic analysis of the anterior cingulate cortex in the major psychiatric disorders: Evidence for disease-associated changes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

Biomarkers and surrogate endpoints: preferred definitions and conceptual framework

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

Prevalence and assessment of attention-deficit/hyperactivity disorder in primary care settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

MRI-based measurement of hippocampal volume in patients with combat-related posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

Reduced density of hypothalamic VGF-immunoreactive neurons in schizophrenia: a potential link to impaired growth factor signaling and energy homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

Proteomic analysis of rat hippocampus after repeated psychosocial stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

Hypo-phosphorylation of salivary peptidome as a clue to the molecular pathogenesis of autism spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

Proteomic analysis of rat cortical neurons after fluoxetine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

Changes in oxidative stress and cellular immunity serum markers in attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

Clinical differences among depressed patients with and without a history of suicide attempts: findings from the STAR*D trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

Structural characterization of fish egg vitelline envelope proteins by mass spectrometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

Isolation and structural characterization of the Ndh complex from mesophyll and bundle sheath chloroplasts of Zea mays

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

Mass spectrometric evidence that proteolytic processing of rainbow trout egg vitelline envelope proteins takes place on the egg.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

Identifying transient protein-protein interactions in EphB2 signaling by blue native PAGE and mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

Biomarkers and neurobiology of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

Molecular genetics of attention deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

Progress and promise of attention-deficit hyperactivity disorder pharmacogenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

Candidate gene studies of ADHD: a meta-analytic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

Common variants in polygenic schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

Correlation between protein and mRNA abundance in yeast

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

Quantitative analysis of complex protein mixtures using isotope-coded affinity tags

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

Fragile X syndrome and targeted treatment trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

HUPO Brain Proteome Project: aims and needs in proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

Mechanisms underlying psychosis and antipsychotic treatment response in schizophrenia: insights from PET and SPECT imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

Integrated genomic and proteomic analyses of a systematically perturbed metabolic network

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

Protein phosphorylation patterns in serum from schizophrenia patients and healthy controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

Proteomic approach for the elucidation of biological defects in autism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

Proteomic studies identified a single nucleotide polymorphism in glyoxalase I as autism susceptibility factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder. The Stanley Neuropathology Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

Proteomic analysis of protein changes developing in rat hippocampus after chronic antidepressant treatment: Implications for depressive disorders and future therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

Depression: an inflammatory illness?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

Linking Molecules to Mood: New Insight Into the Biology of Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

Anti-Inflammatory effects of antidepressants through suppression of the interferon-gamma/interleukin-10 production ratio.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

Stimulatory effect of antidepressants on the production of IL-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

Biomarkers in psychiatry: drawbacks and potential for misuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

Schizophrenia proteomics: biomarkers on the path to laboratory medicine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

Schizophrenia genomics and proteomics: are we any closer to biomarker discovery?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

Global proteomic profiling reveals altered proteomic signature in schizophrenia serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

Identifying blood biomarkers for mood disorders using convergent functional genomics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

Use of biomarkers and surrogate endpoints in drug development and regulatory decision making: criteria, validation, strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

Inflammatory biomarkers in depression: an opportunity for novel therapeutic interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

The immunoregulatory effects of antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

Is the word 'biomarker' being properly used by proteomics research in neuroscience?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

Proteome analysis of schizophrenia brain tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

Proteome analysis of the thalamus and cerebrospinal fluid reveals glycolysis dysfunction and potential biomarkers candidates for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

The role of proteomics in depression research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

Elevated cytokine levels in children with autism spectrum disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

Development of an LC-MS/MS method for the analysis of serotonin and related compounds in urine and the identification of a potential biomarker for attention deficit hyperactivity/hyperkinetic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

Development of a nano-electrospray MSn method for the analysis of serotonin and related compounds in urine using a LTQ-orbitrap mass spectrometer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

Neurogenesis and major depression: implications from proteomic analyses of hippocampal proteins in a rat depression model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

A comparison of qEEG and HMPAO-SPECT in relation to the clinical severity of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

Inflammatory biomarkers and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

Patterns and rates of exonic de novo mutations in autism spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

Meta-analysis of 32 genome-wide linkage studies of schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

Investigation of stable and transient protein-protein interactions: Past, present, and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

Automated mass spectrometry-based functional assay for the routine analysis of the secretome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

Biomarkers of clinical benefit for anti-epidermal growth factor receptor agents in patients with non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

Integrated genome-wide association study findings: identification of a neurodevelopmental network for attention deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

Biomarker-based selection of therapy for colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

Structural investigation of tumor differentiation factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

Biomarkers and attention-deficit/hyperactivity disorder: a systematic review and meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

Mood disorders are glial disorders: evidence from in vivo studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

Glial pathology is modified by age in mood disorders--a systematic meta-analysis of serum S100B in vivo studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

Biomarkers in psychiatry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

Glutamate-based antidepressants: 20 years on.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

Proteomic analysis of plasma membranes isolated from undifferentiated and differentiated HepaRG cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

Disulfide proteomics for identification of extracellular or secreted proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

Identification of a potential tumor differentiation factor receptor candidate in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

Characterization of tumor differentiation factor (TDF) and its receptor (TDF-R).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

Mass spectrometry investigation of glycosylation on the NXS/T sites in recombinant glycoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

Lipid profile, fatty acid composition and pro- and anti-oxidant status in pediatric patients with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

Stable isotopic labeling by amino acids in cultured primary neurons: application to brain-derived neurotrophic factor-dependent phosphotyrosine-associated signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

HUPO Brain Proteome Project Pilot Studies: bioinformatics at work

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

Etiologic subtypes of attention-deficit/hyperactivity disorder: brain imaging, molecular genetic and environmental factors and the dopamine hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

Serum protein profiling and proteomics in autistic spectrum disorder using magnetic bead-assisted mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

Proteomic research in psychiatry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

Biomarkers for attention-deficit/hyperactivity disorder (ADHD). A consensus report of the WFSBP task force on biological markers and the World Federation of ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

Proteome-based pathway modelling of psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

Cerebrospinal fluid biomarker candidates of schizophrenia: where do we stand?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

Two-dimensional difference gel electrophoresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

Autobiographical memory in depression: an fMRI study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

Progress with proteome projects: why all proteins expressed by a genome should be identified and how to do it.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

International Study to Predict Optimized Treatment for Depression (iSPOT-D), a randomized clinical trial: rationale and protocol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

Potential biomarkers in psychiatry: focus on the cholesterol system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

Identification of consistent alkylation of cysteine-less peptides in a proteomics experiment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

Treating clients with Asperger's syndrome and autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

Mass spectrometry as a tool for studying autism spectrum disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

Altered levels of acute phase proteins in the plasma of patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

Cerebrospinal fluid and serum markers of inflammation in autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1134-6

Mass spectrometry-based label-free quantitative proteomics

21 January 2018

1 reference

12 December 2020

A proteomic study of serum from children with autism showing differential expression of apolipoproteins and complement proteins

1 reference

12 December 2020

Mass spectrometry for the detection of potential psychiatric biomarkers

1 reference

12 December 2020

Protein-protein interactions: switch from classical methods to proteomics and bioinformatics-based approaches

1 reference

12 December 2020

The symptoms, neurobiology, and current pharmacological treatment of depression

1 reference

12 December 2020

Psychiatric Diagnosis and the Pathologist's View of Schizophrenia.

1 reference

12 December 2020

Molecules, signaling, and schizophrenia

1 reference

12 December 2020

Attention deficit hyperactivity disorder pharmacogenetics: the dopamine transporter and D4 receptor

1 reference

12 December 2020

Prevalence of autism spectrum disorders--Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2008

1 reference

12 December 2020

The WHO World Health Report 2001 on mental health.

1 reference

12 December 2020

Salivary tau species are potential biomarkers of Alzheimer's disease

1 reference

12 December 2020

Neuroimaging of schizophrenia: what it reveals about the disease and what it tells us about a patient

1 reference

12 December 2020

Diagnosis of attention deficit hyperactivity disorder: much ado about something

1 reference

12 December 2020

Advancing civil rights, the next generation: the Genetic Information Nondiscrimination Act of 2008 and beyond.

1 reference

12 December 2020

Common polygenic variation contributes to risk of schizophrenia and bipolar disorder

1 reference

12 December 2020

10.1007/S00702-013-1134-6

Identifiers

DOI

1 reference

30 August 2017

1 reference